The company has already filed 2 DMFs with US FDA and 6 Common Technical Documents (CTDs) with European Authorities. CTD is the latest form of application for regulatory approvals in European Union countries.
The company has two API (Active Pharmaceutical Ingredients) facilities comprising of 14 blocks and two formulation facilities comprising of 15 modules gearing up for approvals from regulated markets.
